The pilot study on the effect of improving the arteriosclerosis index,blood lipid metabolism, coagulation and fibrinolysis by oral ingestion of collagen tripeptide.

The pilot study on the effect of improving the arteriosclerosis index,blood lipid metabolism, coagulation and fibrinolysis by oral ingestion of collagen tripeptide. - The pilot study on the effect of improving the arteriosclerosis index,blood lipid metabolism, coagulation and fibrinolysis by oral ingestion of collagen tripeptide.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018525

Enrollment

Registered

2015-08-03

Start date

2013-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

Interventions

CTP-15(Collagen tripeptide) 16g/BID 6months

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Volunteer.(Men and women over the age of 40) 2. Person who are not taking EPA. 3. Person who can obtain the document consent.

Exclusion criteria

Exclusion criteria: 1. Person with gelatin allergy. 2. Women who is pregnant,or breast-feeding,or planning to become pregnant. 3.Person who responsible investigator has determined that inappropriate.

Design outcomes

Primary

Measure	Time frame
FMD,CAVI	—

Secondary

Measure	Time frame
Total-cholesterol,HDL-cholesterol,LDL-cholesterol,TG FDP,D-D dimer	—

Countries

Japan

Contacts

Public ContactMasanori Aikawa

Kanazawa Medical University Hospital Clinical Reseach and Trials Center

tiken@kanazawa-med.ac.jp076-218-8347

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026